NZ598927A - Antiviral nucleoside analogs - Google Patents
Antiviral nucleoside analogsInfo
- Publication number
- NZ598927A NZ598927A NZ598927A NZ59892708A NZ598927A NZ 598927 A NZ598927 A NZ 598927A NZ 598927 A NZ598927 A NZ 598927A NZ 59892708 A NZ59892708 A NZ 59892708A NZ 598927 A NZ598927 A NZ 598927A
- Authority
- NZ
- New Zealand
- Prior art keywords
- compounds
- methyltetrahydrofuran
- triazin
- hydroxymethyl
- diol
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/23—Heterocyclic radicals containing two or more heterocyclic rings condensed among themselves or condensed with a common carbocyclic ring system, not provided for in groups C07H19/14 - C07H19/22
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Oncology (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US88027807P | 2007-01-12 | 2007-01-12 | |
| PCT/US2008/050929 WO2008089105A2 (en) | 2007-01-12 | 2008-01-11 | Antiviral nucleoside analogs |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ598927A true NZ598927A (en) | 2013-09-27 |
Family
ID=39471795
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ598927A NZ598927A (en) | 2007-01-12 | 2008-01-11 | Antiviral nucleoside analogs |
| NZ578556A NZ578556A (en) | 2007-01-12 | 2008-01-11 | Antiviral nucleoside analogs |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ578556A NZ578556A (en) | 2007-01-12 | 2008-01-11 | Antiviral nucleoside analogs |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US8440813B2 (enExample) |
| EP (2) | EP2535345A1 (enExample) |
| JP (1) | JP2010515760A (enExample) |
| CN (1) | CN101611046A (enExample) |
| AU (1) | AU2008206406A1 (enExample) |
| CA (1) | CA2674589A1 (enExample) |
| CY (1) | CY1113282T1 (enExample) |
| DK (1) | DK2114980T3 (enExample) |
| ES (1) | ES2390188T3 (enExample) |
| HR (1) | HRP20120758T1 (enExample) |
| IL (1) | IL199664A0 (enExample) |
| MX (1) | MX2009007333A (enExample) |
| NZ (2) | NZ598927A (enExample) |
| PH (1) | PH12012502284A1 (enExample) |
| PL (1) | PL2114980T3 (enExample) |
| PT (1) | PT2114980E (enExample) |
| SG (1) | SG177974A1 (enExample) |
| SI (1) | SI2114980T1 (enExample) |
| WO (1) | WO2008089105A2 (enExample) |
Families Citing this family (97)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8124759B2 (en) * | 2007-05-09 | 2012-02-28 | Abbott Laboratories | Inhibitors of protein kinases |
| US8242085B2 (en) | 2007-05-10 | 2012-08-14 | Biocryst Pharmaceuticals, Inc. | Tetrahydrofuro [3,4-D] dioxolane compounds for use in the treatment of viral infections and cancer |
| TW200942243A (en) * | 2008-03-05 | 2009-10-16 | Biocryst Pharm Inc | Antiviral therapeutic agents |
| US20090247750A1 (en) * | 2008-03-28 | 2009-10-01 | Biocryst Pharmaceuticals, Inc. | Process for preparing nucleoside analogs |
| EA020659B1 (ru) | 2008-04-23 | 2014-12-30 | Джилид Сайэнс, Инк. | 1'-замещённые карбануклеозидные аналоги для противовирусной терапии |
| WO2010002877A2 (en) | 2008-07-03 | 2010-01-07 | Biota Scientific Management | Bycyclic nucleosides and nucleotides as therapeutic agents |
| JP5746638B2 (ja) | 2009-02-10 | 2015-07-08 | ギリアード サイエンシーズ， インコーポレイテッド | 抗ウイルス処置のためのカルバ−ヌクレオシドアナログ |
| US8455451B2 (en) | 2009-09-21 | 2013-06-04 | Gilead Sciences, Inc. | 2'-fluoro substituted carba-nucleoside analogs for antiviral treatment |
| CN102596979B (zh) | 2009-09-21 | 2014-12-10 | 吉里德科学公司 | 用于制备1’-取代碳核苷类似物的方法和中间体 |
| US7973013B2 (en) | 2009-09-21 | 2011-07-05 | Gilead Sciences, Inc. | 2'-fluoro substituted carba-nucleoside analogs for antiviral treatment |
| CA2773772C (en) * | 2009-09-21 | 2018-06-26 | Gilead Sciences, Inc. | 2'-fluoro substituted carba-nucleoside analogs for antiviral treatment |
| US8791257B2 (en) | 2010-03-31 | 2014-07-29 | Bristol-Myers Squibb Company | Substituted pyrrolotriazines as protein kinase inhibitors |
| TW201201815A (en) | 2010-05-28 | 2012-01-16 | Gilead Sciences Inc | 1'-substituted-carba-nucleoside prodrugs for antiviral treatment |
| ES2524398T3 (es) | 2010-07-19 | 2014-12-09 | Gilead Sciences, Inc. | Métodos para la preparación de profármacos de fosforoamidato diastereoméricamente puros |
| EA025252B1 (ru) | 2010-07-22 | 2016-12-30 | Гайлид Сайэнсиз, Инк. | Способы и соединения для лечения вирусных инфекций paramyxoviridae |
| TW201305185A (zh) * | 2010-09-13 | 2013-02-01 | Gilead Sciences Inc | 用於抗病毒治療之２’－氟取代之碳－核苷類似物 |
| AP3699A (en) | 2010-09-20 | 2016-05-31 | Gilead Sciences Inc | 2'-fluoro substituted carba-nucleoside analogs for antiviral treatment |
| CA2812962C (en) | 2010-09-22 | 2020-03-31 | Alios Biopharma, Inc. | Azido nucleosides and nucleotide analogs |
| US8754114B2 (en) | 2010-12-22 | 2014-06-17 | Incyte Corporation | Substituted imidazopyridazines and benzimidazoles as inhibitors of FGFR3 |
| WO2012142523A2 (en) | 2011-04-13 | 2012-10-18 | Gilead Sciences, Inc. | 1'-substituted pyrimidine n-nucleoside analogs for antiviral treatment |
| SG195100A1 (en) | 2011-07-01 | 2013-12-30 | Bayer Ip Gmbh | Hydroxymethylaryl-substituted pyrrolotriazines as alk1 inhibitors |
| AR088441A1 (es) | 2011-09-12 | 2014-06-11 | Idenix Pharmaceuticals Inc | Compuestos de carboniloximetilfosforamidato sustituido y composiciones farmaceuticas para el tratamiento de infecciones virales |
| CA2752008A1 (en) | 2011-09-13 | 2013-03-13 | Universite De Montreal | Combination therapy using ribavirin as elf4e inhibitor |
| AU2012358803C1 (en) | 2011-12-22 | 2019-12-19 | Janssen Biopharma, Inc. | Substituted nucleosides, nucleotides and analogs thereof |
| CN106749272B (zh) | 2012-03-13 | 2019-08-30 | 吉利德科学公司 | 用于抗病毒治疗的2’-取代的卡巴-核苷类似物 |
| US9441007B2 (en) | 2012-03-21 | 2016-09-13 | Alios Biopharma, Inc. | Substituted nucleosides, nucleotides and analogs thereof |
| USRE48171E1 (en) | 2012-03-21 | 2020-08-25 | Janssen Biopharma, Inc. | Substituted nucleosides, nucleotides and analogs thereof |
| AR090699A1 (es) | 2012-04-18 | 2014-12-03 | Biocryst Pharm Inc | Compuestos inhibidores de la actividad de la arn polimerasa viral |
| CN107652289B (zh) | 2012-06-13 | 2020-07-21 | 因塞特控股公司 | 作为fgfr抑制剂的取代的三环化合物 |
| US9388185B2 (en) | 2012-08-10 | 2016-07-12 | Incyte Holdings Corporation | Substituted pyrrolo[2,3-b]pyrazines as FGFR inhibitors |
| CA2890905A1 (en) * | 2012-11-16 | 2014-05-22 | Biocryst Pharmaceuticals, Inc. | Antiviral azasugar-containing nucleosides |
| US9266892B2 (en) | 2012-12-19 | 2016-02-23 | Incyte Holdings Corporation | Fused pyrazoles as FGFR inhibitors |
| JP6449244B2 (ja) | 2013-04-19 | 2019-01-09 | インサイト・ホールディングス・コーポレイションＩｎｃｙｔｅ Ｈｏｌｄｉｎｇｓ Ｃｏｒｐｏｒａｔｉｏｎ | Ｆｇｆｒ抑制剤としての二環式複素環 |
| US9862743B2 (en) | 2013-10-11 | 2018-01-09 | Alios Biopharma, Inc. | Substituted nucleosides, nucleotides and analogs thereof |
| UA119050C2 (uk) | 2013-11-11 | 2019-04-25 | Ґілеад Саєнсиз, Інк. | ПІРОЛО[1.2-f][1.2.4]ТРИАЗИНИ, ЯКІ ВИКОРИСТОВУЮТЬСЯ ДЛЯ ЛІКУВАННЯ РЕСПІРАТОРНО-СИНЦИТІАЛЬНИХ ВІРУСНИХ ІНФЕКЦІЙ |
| WO2015143712A1 (en) | 2014-03-28 | 2015-10-01 | Merck Sharp & Dohme Corp. | 4'-substituted nucleoside reverse transcriptase inhibitors |
| TWI678369B (zh) | 2014-07-28 | 2019-12-01 | 美商基利科學股份有限公司 | 用於治療呼吸道合胞病毒感染之噻吩並［３,２-ｄ］嘧啶、呋喃並［３,２-ｄ］嘧啶及吡咯並［３,２-ｄ］嘧啶化合物類 |
| TWI673283B (zh) | 2014-08-21 | 2019-10-01 | 美商基利科學股份有限公司 | ２’－氯胺基嘧啶酮及嘧啶二酮核苷類 |
| US10214537B2 (en) | 2014-10-22 | 2019-02-26 | Bristol-Myers Squibb Company | Bicyclic heteroaryl amine compounds |
| WO2016064958A1 (en) | 2014-10-22 | 2016-04-28 | Bristol-Myers Squibb Company | Heteroaryl substituted pyrrolotriazine amine compounds as pi3k inhibitors |
| US10851105B2 (en) | 2014-10-22 | 2020-12-01 | Incyte Corporation | Bicyclic heterocycles as FGFR4 inhibitors |
| TWI698444B (zh) * | 2014-10-29 | 2020-07-11 | 美商基利科學股份有限公司 | 製備核糖苷的方法 |
| WO2016134294A1 (en) | 2015-02-20 | 2016-08-25 | Incyte Corporation | Bicyclic heterocycles as fgfr4 inhibitors |
| ES2751669T3 (es) | 2015-02-20 | 2020-04-01 | Incyte Corp | Heterociclos bicíclicos como inhibidores FGFR |
| MA41551A (fr) | 2015-02-20 | 2017-12-26 | Incyte Corp | Hétérocycles bicycliques utilisés en tant qu'inhibiteurs de fgfr4 |
| GEP20237502B (en) | 2015-03-06 | 2023-04-25 | Atea Pharmaceuticals Inc | B-D-2'-DEOXY-2'a-FLUORO-2'-B-C-SUBSTITUTED-2-MODIFIED-N6-SUBSTITUTED PURINE NUCLEOTIDES FOR HCV TREATMENT |
| CN104876935B (zh) * | 2015-05-18 | 2017-04-19 | 南方医科大学 | 2‑氨基吡咯并[1,2‑f][1,2,4]三嗪类化合物、合成方法及应用 |
| MA52371A (fr) | 2015-09-16 | 2021-09-22 | Gilead Sciences Inc | Méthodes de traitement d'infections dues aux coronaviridae |
| AU2016328303B2 (en) | 2015-09-23 | 2019-05-02 | Merck Sharp & Dohme (Uk) Limited | 4'-substituted nucleoside reverse transcriptase inhibitors and preparations thereof |
| WO2017155949A1 (en) | 2016-03-09 | 2017-09-14 | Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center | Methods and kits for use in preventing and treating vulvovaginal candidiasis |
| TWI740910B (zh) | 2016-03-09 | 2021-10-01 | 美商艾洛斯生物製藥公司 | 非環抗病毒劑 |
| HUE064656T2 (hu) | 2016-03-28 | 2024-04-28 | Incyte Corp | Pirrolotriazin vegyületek mint TAM inhibitorok |
| US10711029B2 (en) | 2016-07-14 | 2020-07-14 | Atea Pharmaceuticals, Inc. | Beta-d-2′-deoxy-2′-alpha-fluoro-2′-beta-c-substituted-4′fluoro-n6-substituted-6-amino-2-substituted purine nucleotides for the treatment of hepatitis c virus infection |
| EA202190602A3 (ru) | 2016-09-07 | 2021-11-30 | Атеа Фармасьютикалс, Инк. | 2'-замещенные-n6-замещенные пуриновые нуклеотиды для лечения вызванных рнк-вирусом заболеваний |
| EP3538108A4 (en) * | 2016-11-10 | 2020-06-17 | Oyagen, Inc. | METHODS OF TREATING AND INHIBITING EBOLA VIRUS INFECTION |
| GEP20237457B (en) | 2017-02-01 | 2023-01-10 | Atea Pharmaceuticals Inc | Nucleotide hemi-sulfate salt for treatment of hepatitis c virus |
| CN110869028B (zh) | 2017-03-14 | 2023-01-20 | 吉利德科学公司 | 治疗猫冠状病毒感染的方法 |
| CN115403626A (zh) | 2017-05-01 | 2022-11-29 | 吉利德科学公司 | 新结晶形式 |
| CN107056775A (zh) * | 2017-05-24 | 2017-08-18 | 佛山科学技术学院 | 丙型肝炎病毒ns5b聚合酶抑制剂 |
| AR111960A1 (es) | 2017-05-26 | 2019-09-04 | Incyte Corp | Formas cristalinas de un inhibidor de fgfr y procesos para su preparación |
| CA3077489A1 (en) | 2017-07-11 | 2019-01-17 | Gilead Sciences, Inc. | Compositions comprising an rna polymerase inhibitor and cyclodextrin for treating viral infections |
| US11040975B2 (en) | 2017-12-08 | 2021-06-22 | Merck Sharp & Dohme Corp. | Carbocyclic nucleoside reverse transcriptase inhibitors |
| JP2021521118A (ja) | 2018-04-10 | 2021-08-26 | アテア ファーマシューティカルズ， インコーポレイテッド | 肝硬変を伴うｈｃｖ感染患者の治療 |
| CN119241541A (zh) | 2018-05-04 | 2025-01-03 | 因赛特公司 | Fgfr抑制剂的固体形式和其制备方法 |
| PE20210919A1 (es) | 2018-05-04 | 2021-05-19 | Incyte Corp | Sales de un inhibidor de fgfr |
| MX2021006993A (es) | 2018-12-12 | 2021-10-22 | Janssen Biopharma Inc | Analogos de nucleosidos de ciclopentilo como antivirales. |
| WO2020185532A1 (en) | 2019-03-08 | 2020-09-17 | Incyte Corporation | Methods of treating cancer with an fgfr inhibitor |
| US11591329B2 (en) | 2019-07-09 | 2023-02-28 | Incyte Corporation | Bicyclic heterocycles as FGFR inhibitors |
| WO2021067374A1 (en) | 2019-10-01 | 2021-04-08 | Incyte Corporation | Bicyclic heterocycles as fgfr inhibitors |
| GEP20247679B (en) | 2019-10-14 | 2024-10-10 | Incyte Corp | Bicyclic heterocycles as fgfr inhibitors |
| US11566028B2 (en) | 2019-10-16 | 2023-01-31 | Incyte Corporation | Bicyclic heterocycles as FGFR inhibitors |
| CA3163875A1 (en) | 2019-12-04 | 2021-06-10 | Incyte Corporation | Tricyclic heterocycles as fgfr inhibitors |
| IL293001A (en) | 2019-12-04 | 2022-07-01 | Incyte Corp | Derivatives of fgfr repressors |
| US12012409B2 (en) | 2020-01-15 | 2024-06-18 | Incyte Corporation | Bicyclic heterocycles as FGFR inhibitors |
| CA3163424A1 (en) | 2020-01-27 | 2021-08-05 | Gilead Sciences, Inc. | Methods for treating sars cov-2 infections |
| WO2021158248A1 (en) | 2020-02-04 | 2021-08-12 | Oyagen, Inc. | Method for treating coronavirus infections |
| CN113214262B (zh) * | 2020-02-05 | 2023-07-07 | 华创合成制药股份有限公司 | 一种含有胍基的化合物及其制备方法和用途 |
| TWI775313B (zh) | 2020-02-18 | 2022-08-21 | 美商基利科學股份有限公司 | 抗病毒化合物 |
| JP7429799B2 (ja) | 2020-02-18 | 2024-02-08 | ギリアード サイエンシーズ， インコーポレイテッド | 抗ウイルス化合物 |
| TWI794742B (zh) | 2020-02-18 | 2023-03-01 | 美商基利科學股份有限公司 | 抗病毒化合物 |
| TWI884403B (zh) | 2020-02-18 | 2025-05-21 | 美商基利科學股份有限公司 | 抗病毒化合物 |
| US10874687B1 (en) | 2020-02-27 | 2020-12-29 | Atea Pharmaceuticals, Inc. | Highly active compounds against COVID-19 |
| TWI890963B (zh) | 2020-03-12 | 2025-07-21 | 美商基利科學股份有限公司 | 1'-氰基核苷之製備方法 |
| CA3172483A1 (en) | 2020-04-06 | 2021-10-14 | Scott Ellis | Inhalation formulations of 1'-cyano substituted carbanucleoside analogs |
| CA3179226A1 (en) | 2020-05-29 | 2021-12-02 | Tomas Cihlar | Remdesivir treatment methods |
| KR102911165B1 (ko) | 2020-06-24 | 2026-01-13 | 길리애드 사이언시즈, 인코포레이티드 | 1'-시아노 뉴클레오시드 유사체 및 이의 용도 |
| CN114190092B (zh) * | 2020-07-14 | 2023-07-18 | 四川大学 | 3-去氧-2-酮糖酸含氮衍生物及其制备方法和用途 |
| SI4204421T1 (sl) | 2020-08-27 | 2024-07-31 | Gilead Sciences, Inc., | Spojine in postopki za zdravljenje virusnih okužb |
| JP2024513575A (ja) | 2021-04-12 | 2024-03-26 | インサイト・コーポレイション | Ｆｇｆｒ阻害剤及びネクチン－４標的化剤を含む併用療法 |
| US11697666B2 (en) | 2021-04-16 | 2023-07-11 | Gilead Sciences, Inc. | Methods of preparing carbanucleosides using amides |
| WO2022261160A1 (en) | 2021-06-09 | 2022-12-15 | Incyte Corporation | Tricyclic heterocycles as fgfr inhibitors |
| AR126101A1 (es) | 2021-06-09 | 2023-09-13 | Incyte Corp | Heterociclos tricíclicos como inhibidores de fgfr |
| KR20240022574A (ko) | 2021-06-17 | 2024-02-20 | 아테아 파마슈티컬즈, 인크. | 유리한 항-hcv 조합 요법 |
| KR20240049311A (ko) | 2021-08-18 | 2024-04-16 | 길리애드 사이언시즈, 인코포레이티드 | 인지질 화합물 및 이의 제조 및 사용 방법 |
| KR20240050362A (ko) | 2021-08-20 | 2024-04-18 | 시오노기 앤드 컴파니, 리미티드 | 바이러스 증식 억제 작용을 갖는 뉴클레오사이드 유도체 및 그들의 프로드러그 |
| IL315102A (en) | 2022-03-02 | 2024-10-01 | Gilead Sciences Inc | COMPOSITIONS AND METHODS FOR THE TREATMENT OF VIRAL INFECTIONS |
| US12357577B1 (en) | 2024-02-02 | 2025-07-15 | Gilead Sciences, Inc. | Pharmaceutical formulations and uses thereof |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CZ20012508A3 (cs) | 1999-01-13 | 2002-02-13 | Genentech, Inc. | Inhibitory serinové proteázy |
| NZ547204A (en) * | 2000-05-26 | 2008-01-31 | Idenix Cayman Ltd | Methods and compositions for treating flaviviruses and pestiviruses |
| WO2003062255A2 (en) * | 2002-01-17 | 2003-07-31 | Ribapharm Inc. | Sugar modified nucleosides as viral replication inhibitors |
| PL1628685T3 (pl) | 2003-04-25 | 2011-05-31 | Gilead Sciences Inc | Przeciwwirusowe analogi fosfonianowe |
| US20050182252A1 (en) | 2004-02-13 | 2005-08-18 | Reddy K. R. | Novel 2'-C-methyl nucleoside derivatives |
| CN101166750A (zh) | 2004-10-29 | 2008-04-23 | 拜奥克里斯特制药公司 | 治疗用呋喃并嘧啶类化合物和噻吩并嘧啶类化合物 |
| TW200942243A (en) * | 2008-03-05 | 2009-10-16 | Biocryst Pharm Inc | Antiviral therapeutic agents |
| WO2010002877A2 (en) * | 2008-07-03 | 2010-01-07 | Biota Scientific Management | Bycyclic nucleosides and nucleotides as therapeutic agents |
-
2008
- 2008-01-11 EP EP12168831A patent/EP2535345A1/en not_active Withdrawn
- 2008-01-11 NZ NZ598927A patent/NZ598927A/xx not_active IP Right Cessation
- 2008-01-11 JP JP2009545720A patent/JP2010515760A/ja active Pending
- 2008-01-11 WO PCT/US2008/050929 patent/WO2008089105A2/en not_active Ceased
- 2008-01-11 CA CA002674589A patent/CA2674589A1/en not_active Abandoned
- 2008-01-11 HR HRP20120758AT patent/HRP20120758T1/hr unknown
- 2008-01-11 AU AU2008206406A patent/AU2008206406A1/en not_active Abandoned
- 2008-01-11 PL PL08727625T patent/PL2114980T3/pl unknown
- 2008-01-11 US US12/522,892 patent/US8440813B2/en active Active
- 2008-01-11 ES ES08727625T patent/ES2390188T3/es active Active
- 2008-01-11 PT PT08727625T patent/PT2114980E/pt unknown
- 2008-01-11 SG SG2012002614A patent/SG177974A1/en unknown
- 2008-01-11 MX MX2009007333A patent/MX2009007333A/es active IP Right Grant
- 2008-01-11 CN CNA2008800038586A patent/CN101611046A/zh active Pending
- 2008-01-11 NZ NZ578556A patent/NZ578556A/en not_active IP Right Cessation
- 2008-01-11 EP EP08727625A patent/EP2114980B1/en not_active Not-in-force
- 2008-01-11 DK DK08727625.9T patent/DK2114980T3/da active
- 2008-01-11 SI SI200830771T patent/SI2114980T1/sl unknown
-
2009
- 2009-07-02 IL IL199664A patent/IL199664A0/en unknown
-
2012
- 2012-09-25 CY CY20121100876T patent/CY1113282T1/el unknown
- 2012-11-20 PH PH12012502284A patent/PH12012502284A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MX2009007333A (es) | 2009-08-31 |
| EP2114980A2 (en) | 2009-11-11 |
| HK1138286A1 (en) | 2010-08-20 |
| CN101611046A (zh) | 2009-12-23 |
| US8440813B2 (en) | 2013-05-14 |
| JP2010515760A (ja) | 2010-05-13 |
| SI2114980T1 (sl) | 2012-11-30 |
| PT2114980E (pt) | 2012-09-25 |
| AU2008206406A1 (en) | 2008-07-24 |
| NZ578556A (en) | 2012-04-27 |
| SG177974A1 (en) | 2012-02-28 |
| EP2535345A1 (en) | 2012-12-19 |
| EP2114980B1 (en) | 2012-06-27 |
| WO2008089105A2 (en) | 2008-07-24 |
| CY1113282T1 (el) | 2016-04-13 |
| HRP20120758T1 (hr) | 2012-10-31 |
| IL199664A0 (en) | 2010-04-15 |
| WO2008089105A3 (en) | 2008-09-12 |
| ES2390188T3 (es) | 2012-11-07 |
| DK2114980T3 (da) | 2012-09-24 |
| PL2114980T3 (pl) | 2012-11-30 |
| CA2674589A1 (en) | 2008-07-24 |
| PH12012502284A1 (en) | 2015-10-12 |
| US20100015094A1 (en) | 2010-01-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ598927A (en) | Antiviral nucleoside analogs | |
| HUE035947T2 (hu) | A (2S,3R,4R,5S,6R)-2-(4-klór-3-benzilfenil)-6-(hidroximetil)tetrahidro-2H-pirán-3,4,5-triol származékainak felhasználása a diabétesz kezelésében | |
| NL300701I1 (enExample) | ||
| IL225672B (en) | Pharmaceutical composition comprising (2s,3s,4r,5r)-2-(4-amino-5h-pyrrolo[3,2-d]pyrimidin-7-yl)-5-(hydroxymethyl)pyrrolidine-3,4-diol for inhibiting rna viral polymerase | |
| NZ601486A (en) | 2',4'-substituted nucleosides as antiviral agents | |
| NZ596301A (en) | Novel 7-deazapurine nucleosides for therapeutic uses | |
| MY150059A (en) | Pyrrolo [2,3-d] pyrimidin derivatives as protein kinase b inhibitors | |
| GEP20125658B (en) | Imidazotriazines and imidazo pyrimidines as kinase inhibitors | |
| GEP20135780B (en) | Novel pyrazolo [3,4-d] pyrimidine derivatives as anti-cancer agents | |
| EP1749830A4 (en) | CURCUMOL DERIVATIVES, COMPOSITION COMPRISING THE SAME, AND THEIR USE FOR THE PRODUCTION OF MEDICAMENTS | |
| NZ606156A (en) | Methods and compounds for treating paramyxoviridae virus infections | |
| MX2010003668A (es) | Derivados de purina sustituidas con primidina. | |
| TW200505919A (en) | DPP-IV inhibitors | |
| TW200637562A (en) | Anti-cancer agent containing α-α-α-trifluorothymidine and thymidine phosphorylase inhibitor in combination | |
| MXPA05010293A (es) | 4-amino[1,2,4]triazolo[4,3-a]quinoxalinas sustituidas. | |
| WO2008070313A3 (en) | 3-(dihydro-1h-pyrazolo [4,3-d] pyrimidin-5-yl)-4-propoxybenzenesulfonamide derivatives and methods of use | |
| JP2015505816A5 (enExample) | ||
| EA200800992A1 (ru) | 2-амино-7,8-дигидро-6н-пиридо[4,3-d]пиримидин-5-оны, способ их получения, способ терапии с их помощью, компонент композиции и композиция на их основе, 2,4-диоксопиперидиновые соединения для их получения | |
| WO2018160855A1 (en) | Selective inhibitors of protein arginine methyltransferase 5 (prmt5) | |
| WO2006124861A3 (en) | Benzofuran compounds | |
| WO2014152566A3 (en) | Methods of synthesizing substituted purine compounds | |
| WO2006116733A3 (en) | Protein kinase inhibitors | |
| WO2006058628A3 (en) | Substituted benzoquinolizines as dpp-iv inhibitors for the treatment of diabetes | |
| WO2009034547A3 (en) | New 4-substituted derivatives of pyrazolo[3,4-d pyrimidine and pyrrolo[2,3-d]pyrimidine and uses thereof | |
| WO2006083949A3 (en) | Sepsis prevention through adenosine receptor modulation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ERR | Error or correction |
Free format text: THE MISSING INVENTOR HAS BEEN ADDED (1276945, KOTIAN, PRAVIN L; 1348301, CHAND, POORAN; 1348303, WU, MINWAN; 1348304, KUMAR, V. SATISH; 3043104, BABU, YARLAGADDA, S.) Effective date: 20131008 |
|
| PSEA | Patent sealed | ||
| LAPS | Patent lapsed |